Inventor
NORMAN TIMOTHY JOHN
GB23 patents
⚠️ This page may combine multiple inventors who share the name “NORMAN TIMOTHY JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB Biopharma SRL
9 patentsUS10705094B2Jul 7, 2020
TNF receptor signaling modulator assay
UCB Biopharma SRL9 citations92
US10883996B2Jan 5, 2021
Methods of identifying signaling modulators of the trimeric TNFa
UCB Biopharma SRL7 citations83
US11448655B2Sep 20, 2022
Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors
UCB Biopharma SRL2 citations73
US11674967B2Jun 13, 2023
Method of identifying potential inhibitors of APO TNFα trimers
UCB Biopharma SRL2 citations71
US12474348B2Nov 18, 2025
Complexes between CD40 and compounds comprising benzimidazole moieties
UCB Biopharma SRL0 citations62
US12018021B2Jun 25, 2024
Thiophene derivatives for the treatment of disorders caused by IgE
UCB Biopharma SRL1 citations56
US12410161B2Sep 9, 2025
Tetrahydrobenzo-quinoline sulfonamides derivative compounds
UCB Biopharma SRL0 citations47
US12577228B2Mar 17, 2026
Dihydrocyclopenta-isoquinoline-sulfonamide derivatives compounds
UCB Biopharma SRL0 citations41
US10842884B2Nov 24, 2020
Endosomolytic agents for gene therapy
UCB Biopharma SRL0 citations37
CELLTECH R&D LTD
5 patentsUS6583301B1Jun 24, 2003
Lipids
CELLTECH R&D LTD17 citations91
US6610700B2Aug 26, 2003
Enamine derivatives
CELLTECH R&D LTD13 citations83
US6780874B2Aug 24, 2004
Enamine derivatives
CELLTECH R&D LTD8 citations73
US7531676B2May 12, 2009
Lipids
CELLTECH R&D LTD7 citations72
US6603041B2Aug 5, 2003
Bicyclic enamide derivatives
CELLTECH R&D LTD0 citations41
UCB PHARMA SA
4 patentsUS7736635B2Jun 15, 2010
Branched molecular scaffolds for linking polymer residues to biologically active moieties
UCB PHARMA SA3 citations62
US7910618B2Mar 22, 2011
Albumin-binding conjugates comprising a fatty acid and PEG
UCB PHARMA SA2 citations60
US7557130B2Jul 7, 2009
Bicyclic heteroaromatic alanines
UCB PHARMA SA3 citations60
US8053564B2Nov 8, 2011
Cross-linked antibodies
UCB PHARMA SA1 citations50
UCB BIOPHARMA SPRL
3 patentsUS10775385B2Sep 15, 2020
Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers
UCB BIOPHARMA SPRL7 citations81
US9550737B2Jan 24, 2017
TNF -α modulating benzimidazoles
UCB BIOPHARMA SPRL4 citations71
US10287299B2May 14, 2019
Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity
UCB BIOPHARMA SPRL1 citations56